A study of utility and safety of chest tube removal regardless of amount of pleural effusion

Utility and safety of chest tube removal regardless of amount of pleural effusion after pulmonary resection: A prospective multicenter randomized trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1032180389

Enrollment

172

Registered

2019-03-20

Start date

2019-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary lung cancer, Metastatic lung tumor, Benign lung tumor Pulmonary resection, postoperative air leak, thoracic drainage

Interventions

Chest drain removal regardless amount of pleural effusion on POD2

Chest drain removal

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent lobectomy or segmentectomy and the amount of pleural effusion > 300mL/24hr on Thopaz or Thopas plus on POD2

Exclusion criteria

Exclusion criteria: Patients without postoperative air leak

Design outcomes

Primary

Measure	Time frame
Occurrence rate of postoperative respiratory adverse events (%)	—

Secondary

Measure	Time frame
Treatment completion rate (%), Duration of drain placement (day), days of hospitalization (day), Postoperative pulmonary function	—

Contacts

Public ContactKazuya Takamochi

Juntendo University Hospital

ktakamo@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026